Provisional Program |
| 09.00 – 09.30 | Registration |
| 09.30 – 09.40 | Opening - Mr. Francis Gurry, Deputy Director General, PCT and Patents, Arbitration and Mediation Center, and Global IP Issues, WIPO
- Dr. Meir Perez Pugatch, University of Haifa & Director of Research Stockholm Network
|
| 09.40 – 10.00 | Overview of current issues, WIPO perspective - Mr. Antony Taubman, Acting Director and Head, Global IP Issues Division, WIPO
|
| | Protection of test data (Chair - Mr. Anthony Taubman) |
| 10.00 – 10.20 | Policy and legal choices - Dr. Meir P. Pugatch [PDF]
|
| 10.20 – 10.40 | Development perspective - Mr. Christoph Spennemann, Legal Expert, Intellectual Property Team, Policy Implementation Section, Division on Investment, Technology and Enterprise Development, United Nations Conference on Trade and Development [PDF]
|
| 10.40 – 11-40 | Sectoral perspectives - 10.40 – 11.00: Mrs. Maria Souleau, Vice President, Patents France, Sanofi Aventis
- 11.00 – 11.20: Ms. Suzette Kox, Senior Director Scientific Affairs, European Generic Medicines Association [PDF]
- 11.20 - 11.40: Ms. Michelle López, Manager, Intellectual Property & Trade, CropLife International [PDF]
|
| 11.40 – 12.00 | WHO perspective - Ms. Karin Timmermanns, Technical Officer, Regional Offices for South-East Asia & Western Pacific, World Health Organization [PDF]
|
| 12.00 – 12.30 | Discussion |
| 12.30 – 14.00 | Lunch break |
| | (Chair - Dr. Meir P. Pugatch) |
| 14.00 – 14.15 | Life Sciences Disputes: the Role of Arbitration and Mediation - Mr. Ignacio de Castro Llamas, Deputy Director and Head, Information and External Relations Section, WIPO Arbitration and Mediation Center [PDF]
|
| | Linkages between product regulation and the patent system |
| 14.15 – 14.30 | "Bolar" Provisions and the WTO dispute ruling: "Canada – Patent Protection for Pharmaceutical Products" - Mr. Roger Kampf, Counsellor, Intellectual Property Division, World Trade Organization [PDF]
|
| 14.30 – 15.00 | Patent term extensions - Ms. Alison Blakey, Patent Counsel & Director IP, Prosidion Limited, Oxford, GB
|
| 15.00 – 15.30 | Coffee break |
| | Other linkages between generic entry and patent system |
| 15.30 – 16.00 | Biosimilars - Marc Markus, Pfizer Brevet, European Patent Department, Paris, France
|
| 16.00 – 17.00 | Linkages between generic approval and the patent system - Ms. Karin Ferriter, Legal Advisor, Office of International Intellectual Property Policy and Enforcement, United States Patent and Trademark Office [ PDF]
- Ms. Erika Veiga, Manager of International Sanitary Regulations, Brazilian National Health Surveillance Agency (Agência Nacional de Vigilância Sanitária - ANVISA) [PDF]
|
| 17.00 – 17.30 | Discussion |